Get your free independent analyst’s take on Generis and the CARA platform: what the company does, how CARA supports regulatory, quality, safety, and clinical programs in life sciences, and Deep Analysis’ own view on where it stands in the market for content, data, and process management. The report also touches on how the same platform is applied in other regulated industries, including financial services, government, and manufacturing. This is a straight-to-the-point read for anyone currently assessing CARA for a life sciences environment and wanting an independent perspective alongside the conversations they’re already having.

Why Deep Analysis

Deep Analysis is an advisory firm focused on enterprise content management, intelligent document processing, and process automation. Led by analyst Alan Pelz-Sharpe, the firm draws on decades of experience advising vendors, buyers, and investors across the space, including SAP, Oracle, and HP.

This isn’t vendor-written content. It’s an outside analyst’s independent assessment, offered as a useful reference point for anyone evaluating options in a regulated life sciences environment.

Download the Deep Analysis Vendor Analysis of Generis and CARA, free.